3,4-Dichlorobenzoic acid → HCID 71541849, compound
Reaction equation
[O:1]=[C:2]1[CH:11]=[CH:10][C:9]2[C:4](=[CH:5][CH:6]=[C:7]([O:12][CH2:13][C:14]([NH:16][NH2:17])=[O:15])[CH:8]=2)[NH:3]1.[Cl:18][C:19]1[CH:20]=[C:21]([CH:25]=[CH:26][C:27]=1[Cl:28])[C:22](O)=O.C(N(CC)CC)C.CCCP(=O)=O>CN(C=O)C>[Cl:18][C:19]1[CH:20]=[C:21]([C:22]2[O:15][C:14]([CH2:13][O:12][C:7]3[CH:8]=[C:9]4[C:4](=[CH:5][CH:6]=3)[NH:3][C:2](=[O:1])[CH:11]=[CH:10]4)=[N:16][N:17]=2)[CH:25]=[CH:26][C:27]=1[Cl:28]Participants
Conditions
- Temperature
- 100 °C
Procedure
To a stirred solution of 2-((2-oxo-1,2-dihydroquinolin-6-yl)oxy)acetohydrazide (0.2 g, 0.858 mmol) and 3,4-dichlorobenzoic acid (0.163 g, 0.858 mmol)) in DMF (8 mL) was added triethylamine (0.598 mL, 4.29 mmol) and propylphosphonic anhydride (T3P) (0.819 g, 2.57 mmol). The reaction mixture was heated at 100° C. overnight under N2 atm. The reaction mixture was concentrated to remove solvent and ice-cold water was added. The precipitate was filtered and washed with water to afford a brown solid. The crude product was purified by preparative HPLC on a C18 reverse phase column (ACN-NH4OAc method) to give 6-((5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl)methoxy)quinolin-2(1H)-one as a white solid (0.016 g, 4.81%). 1H NMR: 400 MHZ, DMSO-d6: δ 5.51 (s, 1H), 6.52 (d, J=9.60 Hz, 1H), 7.27-7.31 (m, 2H), 7.43 (d, J=2.40 Hz, 1H), 7.83-7.92 (m, 2H), 8.00 (dd, J=1.60, 8.40 Hz, 1H), 8.21 (d, J=1.60 Hz, 1H), 11.68 (s, 1H). LCMS: RT 1.92 min. LCMS (ES-API), m/z 390.0 (M+H).
Workup
- concentrationThe reaction mixture was concentrated
- customto remove solvent and ice-cold water
- additionwas added
- filtrationThe precipitate was filtered
- washwashed with water
- customto afford a brown solid
- customThe crude product was purified by preparative HPLC on a C18 reverse phase column (ACN-NH4OAc method)
Sources & evidence
- ORD record
- ord-20e63d7f0e754c8198839da486bc0165
- Source dataset
- uspto-grants-2014_05
- Patent number
- US08722670B2
Reaction notes
Loading…